Search Count: 1,105
All
Selected
 |
Cryo-Em Consensus Map Of Prefusion Sars-Cov-2 Spike (Rbds: 1 Up & 2 Down) Bound To Rbd-Targeting Mo176-117 Antibody
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2026-03-04 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Cryo-Em Focus Map Of Prefusion Sars-Cov-2 Spike (Rbds: 1 Up & 2 Down) Bound To Rbd-Targeting Mo176-117 Antibody
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2026-03-04 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Cryo-Em Consensus Map Of Prefusion Sars-Cov-2 Spike (Rbds: 2 Up & 1 Down) Bound To Rbd-Targeting Mo176-117 Antibody
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2026-03-04 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Cryo-Em Focus Map Of Prefusion Sars-Cov-2 Spike (Rbds: 2 Up & 1 Down) Bound To Rbd-Targeting Mo176-117 Antibody
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2026-03-04 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Enterococcus casseliflavus
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2026-03-04 Classification: ANTIBIOTIC Ligands: A1I8A, DMS |
 |
Organism: Enterococcus casseliflavus
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2026-03-04 Classification: ANTIBIOTIC Ligands: A1I8G, DMS |
 |
Organism: Enterococcus casseliflavus
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2026-02-11 Classification: ANTIBIOTIC Ligands: A1I7K, DMS |
 |
Organism: Enterococcus casseliflavus
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2026-02-11 Classification: ANTIBIOTIC Ligands: A1I72, DMS |
 |
Organism: Enterococcus casseliflavus
Method: X-RAY DIFFRACTION Resolution:2.38 Å Release Date: 2026-02-11 Classification: ANTIBIOTIC Ligands: A1I73, DMS |
 |
Organism: Enterococcus casseliflavus
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2026-02-11 Classification: ANTIBIOTIC Ligands: DMS, A1I74 |
 |
Organism: Enterococcus casseliflavus
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2026-02-11 Classification: ANTIBIOTIC Ligands: A1I75 |
 |
Organism: Enterococcus casseliflavus
Method: X-RAY DIFFRACTION Resolution:2.11 Å Release Date: 2026-02-11 Classification: ANTIBIOTIC Ligands: A1I79, DMS |
 |
Organism: Enterococcus casseliflavus
Method: X-RAY DIFFRACTION Resolution:2.41 Å Release Date: 2026-02-11 Classification: ANTIBIOTIC Ligands: A1I78, DMS |
 |
Organism: Enterococcus casseliflavus
Method: X-RAY DIFFRACTION Resolution:2.29 Å Release Date: 2026-02-11 Classification: ANTIBIOTIC Ligands: A1I8B, DMS |
 |
Organism: Enterococcus casseliflavus
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2026-02-11 Classification: ANTIBIOTIC Ligands: DMS, A1I77 |
 |
Organism: Enterococcus casseliflavus
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2026-02-11 Classification: ANTIBIOTIC Ligands: A1I8F, DMS |
 |
Organism: Enterococcus casseliflavus
Method: X-RAY DIFFRACTION Resolution:2.13 Å Release Date: 2026-02-11 Classification: ANTIBIOTIC Ligands: PWD |
 |
Organism: Enterococcus casseliflavus
Method: X-RAY DIFFRACTION Resolution:2.13 Å Release Date: 2026-02-11 Classification: ANTIBIOTIC Ligands: A1I8E, DMS |
 |
Organism: Pseudomonas aeruginosa
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2026-02-11 Classification: ANTIBIOTIC Ligands: A1I8B |
 |
Organism: Enterococcus casseliflavus
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2026-02-11 Classification: ANTIBIOTIC Ligands: A1I84, DMS |